An experimental Pfizer drug extended the lives of patients who had a disease in which clumps of protein break apart into toxic substances that damage the heart.
Pfizer Drug Reduces Death Rate In Patients With Hearts Damaged By Protein Clumps
An experimental Pfizer drug extended the lives of patients who had a disease in which clumps of protein break apart into toxic substances that damage the heart.